Add to ORKGpercutaneous transluminal septal myocardial abla-tion (PTSMA) has been recently introduced as a nonsurgical treatment for symptomatic hypertrophic cardiomyopathy (HCM).8-11 This procedure enlarges the narrow LVOT by injection of ethanol, causing necrosis of the hypertrophied septum and confers symptomatic improvement. In this article, we report on 3 patients with HOCM who were suffering from PAF refractory to medical treatment. Successful PTSMA not only improved their symptoms associ-ated with LV intracavity obstruction but also signifi-cantly decreased the frequency of PAF episodes
Background: Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease with a var...
Obstruction in hypertrophic cardiomyopathy is associated with increased morbidity and mortality. Eff...
AbstractObjectivesThis study was conducted to evaluate follow-up results in patients with hypertroph...
percutaneous transluminal septal myocardial abla-tion (PTSMA) has been recently introduced as a nons...
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fi xed...
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fixed ...
Introduction. Familial hypertrophic cardiomyopathy (HCM) occurs as an autosomal dominant mendelian i...
We hypothesized that relief of obstruction in patients with hypertrophic cardiomyopathy (HC) by perc...
AbstractObjectives. We report the acute results and midterm clinical course after percutaneous trans...
Objective: Hypertrophic obstructive cardiomyopathy (HOCM) often leads to heart failure, severe sympt...
Percutaneous septal ablation has emerged as a less invasive treatment of symptomatic patients with h...
Hypertrophic cardiomyopathy (HCM) is a highly heterogeneous disease with varied patterns of hypertro...
Hypertrophic cardiomyopathy (HCM) is a complex gen-etic disease associated with sudden death or card...
Background: Percutaneous transluminal septal myocardial ablation (PTSMA) and modified Morrow septal ...
OBJECTIVE: To analyze the efficacy of percutaneous transluminal septal alcoholization in the treatme...
Background: Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease with a var...
Obstruction in hypertrophic cardiomyopathy is associated with increased morbidity and mortality. Eff...
AbstractObjectivesThis study was conducted to evaluate follow-up results in patients with hypertroph...
percutaneous transluminal septal myocardial abla-tion (PTSMA) has been recently introduced as a nons...
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fi xed...
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fixed ...
Introduction. Familial hypertrophic cardiomyopathy (HCM) occurs as an autosomal dominant mendelian i...
We hypothesized that relief of obstruction in patients with hypertrophic cardiomyopathy (HC) by perc...
AbstractObjectives. We report the acute results and midterm clinical course after percutaneous trans...
Objective: Hypertrophic obstructive cardiomyopathy (HOCM) often leads to heart failure, severe sympt...
Percutaneous septal ablation has emerged as a less invasive treatment of symptomatic patients with h...
Hypertrophic cardiomyopathy (HCM) is a highly heterogeneous disease with varied patterns of hypertro...
Hypertrophic cardiomyopathy (HCM) is a complex gen-etic disease associated with sudden death or card...
Background: Percutaneous transluminal septal myocardial ablation (PTSMA) and modified Morrow septal ...
OBJECTIVE: To analyze the efficacy of percutaneous transluminal septal alcoholization in the treatme...
Background: Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease with a var...
Obstruction in hypertrophic cardiomyopathy is associated with increased morbidity and mortality. Eff...
AbstractObjectivesThis study was conducted to evaluate follow-up results in patients with hypertroph...